-
-
-
-
-
-
-
Kadima sues NRx Pharmaceuticals over failed acquisition deal
-
-
-
-
-
-
-
NRx Pharmaceuticals receives FDA clearance for depression trial
-
-
-
-
-
-
-
NRx Pharmaceuticals receives FDA preliminary labeling approval for ketamine
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NRXP) PT Raised to $45 at H.C. Wainwright
-
-
-
-
-
-
-
NRx Pharmaceuticals (NRXP) files $150M mixed shelf
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
-
-
-
-
-
-
-
NRX Pharmaceuticals launches expanded access for ketamine treatment
-
459,696 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

